Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage trial testing its ability to reduce symptoms in…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/vistagens-anxiety-disorder-drug-misses-main-goal-late-stage-2026a1000m97?src=rss
Author :
Publish date : 2026-06-30 13:24:00
Copyright for syndicated content belongs to the linked Source.
